Efficacy of live, attenuated, human rotavirus vaccine 89–12 in infants: a randomised placebo-controlled trial

[1]  R. Feigin,et al.  Textbook of Pediatric Infectious Diseases , 1986 .

[2]  D. Sack,et al.  Reactivities of serotyping monoclonal antibodies with culture-adapted human rotaviruses , 1991, Journal of clinical microbiology.

[3]  R. Ward,et al.  Development of an improved method for measuring neutralizing antibody to rotavirus. , 1991, Journal of virological methods.

[4]  D. Bernstein,et al.  Protection from rotavirus reinfection: 2-year prospective study. , 1991, The Journal of infectious diseases.

[5]  D. Bernstein,et al.  Protection against rotavirus disease after natural rotavirus infection. US Rotavirus Vaccine Efficacy Group. , 1994, The Journal of infectious diseases.

[6]  R. Glass,et al.  Evaluation of Rhesus Rotavirus Monovalent and Tetravalent Reassortant Vaccines in US Children , 1995 .

[7]  R. Glass,et al.  Evaluation of rhesus rotavirus monovalent and tetravalent reassortant vaccines in US children. US Rotavirus Vaccine Efficacy Group. , 1995, JAMA.

[8]  R. Ward.  Mechanisms of protection against rotavirus in humans and mice. , 1996, The Journal of infectious diseases.

[9]  R. Glass,et al.  Safety and Efficacy of High-dose Rhesus-Human Reassortant Rotavirus Vaccines-Report of the National Multicenter Trial , 1996, Pediatrics.

[10]  R. Glass,et al.  Rotavirus infection in infants as protection against subsequent infections. , 1996, The New England journal of medicine.

[11]  R. Glass,et al.  Rotavirus vaccines at the threshold , 1997, Nature Medicine.

[12]  X. Pang,et al.  Randomised placebo-controlled trial of rhesus-human reassortant rotavirus vaccine for prevention of severe rotavirus gastroenteritis , 1997, The Lancet.

[13]  D. Bernstein,et al.  Safety and immunogenicity of live, attenuated human rotavirus vaccine 89-12. , 1998, Vaccine.

[14]  T. Vesikari,et al.  Symptoms associated with rhesus-human reassortant rotavirus vaccine in infants. , 1998, The Pediatric infectious disease journal.

[15]  R. Holman,et al.  Cost-effectiveness analysis of a rotavirus immunization program for the United States. , 1995, JAMA.

[16]  L. Moulton,et al.  The protective effectiveness of natural rotavirus infection in an American Indian population. , 1998, The Journal of infectious diseases.